Its overexpression enhances DNA synthesis and cell growth, while inhibition restores PTEN expression, reduces AKT activation, and promotes apoptosis, underscoring the miR-21/PTEN/AKT axis as a critical driver of keloid formation and a potential therapeutic target (Liu et al., 2014). The gene discussed is AKT1; the disease is keloid.